[HTML][HTML] Convalescent plasma in Covid-19: Possible mechanisms of action

M Rojas, Y Rodríguez, DM Monsalve… - Autoimmunity …, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the
coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including …

JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease

R Fukazawa, J Kobayashi, M Ayusawa… - Circulation …, 2020 - jstage.jst.go.jp
More than 50 years have passed since Kawasaki disease (KD) was first reported. 1
According to a nationwide survey, the number of patients with KD who became adults was …

Expression, role, and regulation of neutrophil Fcγ receptors

Y Wang, F Jönsson - Frontiers in immunology, 2019 - frontiersin.org
Neutrophils are best known for their critical role in host defense, for which they utilize
multiple innate immune mechanisms, including microbe-associated pattern recognition …

Dissecting Kawasaki disease: a state-of-the-art review

SM Dietz, D Van Stijn, D Burgner, M Levin… - European journal of …, 2017 - Springer
Kawasaki disease (KD) is a pediatric vasculitis with coronary artery aneurysms (CAA) as its
main complication. The diagnosis is based on the presence of persistent fever and clinical …

Neither soyfoods nor isoflavones warrant classification as endocrine disruptors: a technical review of the observational and clinical data

M Messina, SB Mejia, A Cassidy… - Critical Reviews in …, 2022 - Taylor & Francis
Soybeans are a rich source of isoflavones, which are classified as phytoestrogens. Despite
numerous proposed benefits, isoflavones are often classified as endocrine disruptors, based …

Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?

SQ Nagelkerke, TW Kuijpers - Frontiers in immunology, 2015 - frontiersin.org
Intravenous IgG (IVIg) contains polyclonal immunoglobulin G (IgG) from thousands of
donors. It is administered at a low dose at regular intervals as antibody replacement therapy …

The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease

JC Burns, A Franco - Expert review of clinical immunology, 2015 - Taylor & Francis
The introduction of intravenous immunoglobulin (IVIG) for modulation of inflammation in
acute Kawasaki disease was a great therapeutic triumph. However, three decades later, the …

Contribution of human FcγRs to disease with evidence from human polymorphisms and transgenic animal studies

C Gillis, A Gouel-Chéron, F Jönsson… - Frontiers in …, 2014 - frontiersin.org
The biological activities of human IgG antibodies predominantly rely on a family of receptors
for the Fc portion of IgG, FcγRs: FcγRI, FcγRIIA, FcγRIIB, FcγRIIC, FcγRIIIA, FcγRIIIB, FcRL5 …

Understanding inter-individual variability in monoclonal antibody disposition

VA Thomas, JP Balthasar - Antibodies, 2019 - mdpi.com
Monoclonal antibodies (mAbs) are currently the largest and most dominant class of
therapeutic proteins. Inter-individual variability has been observed for several mAbs; …

Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis

S Bayers, ST Shulman, AS Paller - Journal of the American Academy of …, 2013 - Elsevier
Kawasaki disease, or mucocutaneous lymph node syndrome, most commonly affects
children between 6 months and 5 years of age. Approximately 90% of patients have …